Loratadine Tablet
Product Images NDC 59556-301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Loratadine (NDC 59556-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (674e40c8 27b8 4621 Afd5 68f544a15d03 01)

Image (674e40c8 27b8 4621 Afd5 68f544a15d03 01)
This is a description for Loratadine Orally Disintegrating Tablets, an antihistamine medication used to relieve symptoms of indoor and outdoor allergies. It comes in 5mg strength and is non-drowsy. It is compared to the active ingredient in Claritin® Reditabs®. The tablets should be immediately used after opening individual blister packs without water. It temporarily prevents sneezing, runny nose, watery and itchy eyes, and itchy throat or nose. The drug facts and directions should be followed carefully to avoid overdose, allergic reactions, or complications in individuals with pre-existing kidney or liver disease. It is manufactured in India and distributed by Strides Pharma Inc. in NJ. The description comes with a packaging label/image of the drug.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.